Four of the top five pediatric hospitals in the U.S., as ranked by U.S. News & World Report, are using a Covalon product, which include wound site and vascular access dressings. Covalon currently has a client base of more than 17 percent of United States pediatric hospitals, according to a Sept. 8 Covalon news release.
“It is not a mystery why 8 of the top 10 pediatric hospitals for cancer treatment in the United States are using Covalon products,” said Brian Pedlar, CEO of Covalon. “Our products are specifically designed to help these patients heal better and safer, as recognized by healthcare providers that have dedicated themselves to the healing of some of our most vulnerable patients — our children.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
